# Response to Anti-hypertensives in Pregnant and Postpartum Patients

> **NCT03506724** · PHASE4 · COMPLETED · sponsor: **Icahn School of Medicine at Mount Sinai** · enrollment: 109 (actual)

## Conditions studied

- Hypertension in Pregnancy
- Preeclampsia

## Interventions

- **DRUG:** Nifedipine
- **DRUG:** Labetalol

## Key facts

- **NCT ID:** NCT03506724
- **Lead sponsor:** Icahn School of Medicine at Mount Sinai
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-09-11
- **Primary completion:** 2019-04-05
- **Final completion:** 2019-04-05
- **Target enrollment:** 109 (ACTUAL)
- **Last updated:** 2021-05-24

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03506724

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03506724, "Response to Anti-hypertensives in Pregnant and Postpartum Patients". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03506724. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*